Skip to content

Stereotaxis STXS Debt Issuance Costs

Debt Issuance Costs at other companies

Novanta logo
NovantaNOVT
$1.29M
Haemonetics logo
HaemoneticsHAE
$0
TFX
TeleflexTFX
$0-100%

Other financials

Income statement

See full
Revenue$6.3M-15.8%
Gross profit$3.8M-6.6%
Operating income-$6.0M-0.9%
Net income-$5.9M-0.7%
EPS (diluted)-$0.06+14.3%

Balance sheet

See full
Cash & equivalents$14.6M+36.7%
Total debt$5.3M-10.0%
Total equity$14.4M+399%
Total assets$54.0M+18.2%

Cash flow

See full
Operating cash flow-$3.4M-93.5%
CapEx$79.0K
Free cash flow-$3.5M

Valuation

See full
Market cap$168.11M-11.6%
Enterprise value$158.77M-15.9%
P/S5.4×-0.6×

Profitability

See full
Gross margin53.9%+0.5pp
Operating margin-71%-14.0pp
Net margin-69.5%-13.7pp
FCF margin-35.5%-2.4pp

Returns & leverage

See full
Return on equity-251.5%-29.9pp
Debt / equity0.4×-1.7×
Current ratio1.6×+0.5×

Where this comes from

Reported directly by Stereotaxis in its filing.

Tagged under the XBRL concept us-gaap:PaymentsOfDebtIssuanceCosts.

The official record: Stereotaxis’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Stereotaxis's debt issuance costs.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Stereotaxis's debt issuance costs?
Stereotaxis (STXS) reported debt issuance costs of $137K in Q1 2026.
How has Stereotaxis's debt issuance costs changed year-over-year?
Stereotaxis's debt issuance costs decreased by 38.6% year-over-year, from $223.25K to $137K.
What does debt issuance costs mean?
Cash paid for fees, legal costs, and underwriting discounts associated with issuing new debt.